Skip to content

Catheter Ablation of Advanced Forms of Atrial Fibrillation

Catheter Ablation of Advanced Forms of Atrial Fibrillation

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07446244
Acronym
ENDO MAZE
Enrollment
50
Registered
2026-03-03
Start date
2026-03-25
Completion date
2028-03-01
Last updated
2026-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent Atrial Fibrillation, Persistent Atrial Fibrillation Longstanding

Keywords

pulsed field ablation, atrial fibrillation, cox maze

Brief summary

The purpose of this study is to evaluate feasibility, safety, and efficacy of pulmonary vein isolation combined with posterior left atrial isolation and multiple linear lesions in both atria in patients with persistent and long-standing persistent atrial fibrillation.

Detailed description

Patients with long-standing and persistent atrial fibrillation with severely dilated left atrium will undergo pulmonary vein isolation, box-lesion set of posterior wall, lateral mitral line (Marshall vein ablation and coronary sinus ablation per operator's discretion, anterior line, cavotricuspid line, superior caval vein isolation, intercaval line and inferior septal line. Ablations will be performed with either radiofrequency energy or pulsed field ablation at operator's discretion. Block at each line will be checked at the end of the procedure. The procedure will be performed with compliance of producer recommendation and hospital protocol. All patients will be invited back at three months after index procedure for an invasive remap. At the remap procedure, pulmonary veins and posterior wall will be checked for isolation and all the additional lines will be checked for conduction block. Any gaps in lines will be ablated per operator's discretion. Patients will undergo a period follow-up visit at 3, 6, and 12-month period. They will undergo a medical history taking, physical examination, ECG, and 7-day Holter ECG. Any documented atrial arrhythmia lasting more than 30 seconds after 8 week blanking period will be documented as a recurrence of atrial fibrillation.

Interventions

DEVICEEndovascular ablation set mimicking cox maze 4 procedure.

Endovascular pulmonary vein isolation, posterior left atrial isolation and multiple linear lesions in both atria using electroporation and radiofrequency energy.

Sponsors

University Medical Centre Ljubljana
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

monocentric prospective nonrandomized cohort study

Eligibility

Sex/Gender
ALL
Age
No minimum to 80 Years
Healthy volunteers
No

Inclusion criteria

* persistent atrial fibrillation or long-standing persistent atrial fibrillation * severely enlarged left atrium (LAVI above 50 ml/m2)

Exclusion criteria

* contraindications for electroporation * contraindications for general anaesthesia * age above 80 years * less than 1 year life expectancy * thrombus formation in left atrium * acute life-threatening disease * severe valvular disease requiring intervention * previous ablation in left atrium * secondary atrial fibrillation

Design outcomes

Primary

MeasureTime frameDescription
Atrial arrhythmia recurrence12 monthsAtrial fibrillation/atrial tachycardia/atrial undulation lasting more than 30s after 8 week blanking period and without antiarrhythmic drug therapy. Assessed with 7-day Holter ECG at 3, 6, 12 months after index procedure.

Secondary

MeasureTime frameDescription
Efficacy of endovascular Cox maze procedure12 monthAtrial fibrillation burden will be assessed with 7-day Holter ECG at 3, 6 and 12 months post procedure.
Interventions12 monthsInitiations of antiarrhythmic drug therapy, number of cardioversions, number of repeat procedures after index procedure will be assessed.
Durability of ablation lines and isolations3 monthsNumber of durable blocks across ablation lines and durable isolations (pulmonary veins, superior vena cava) on invasive remap at 3 months will be assessed.
Safety of catheter ablation procedure6 monthsIncidence of adverse events defined as events, which require prolonged hospitalization, additional intervention or permanent damage to patients health or cause death in a 180 day period after catheter ablation.

Countries

Slovenia

Contacts

PRINCIPAL_INVESTIGATORTine Prolic Kalinsek, MD

UMCL

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 7, 2026